PERK

PERK製品

  • All (9)
  • PERK阻害剤 (3)
  • PERK活性剤(3)
  • PERKモジュレータ(3)
  • 新製品
製品コード 製品名称 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S7307 GSK2606414 GSK2606414 is an orally available, potent, and selective PERK inhibitor with IC50 of 0.4 nM, displaying at least 100-fold selectivity over the other EIF2AKs assayed. GSK2606414 impairs GANT-61 induced autophagy in NB cells with MYCN amplification. GSK2606414 exacerbates ER stress-induced apoptosis in HCT116 cells while reduces the apoptosis in SIL1 KD HeLa cells.
Exp Mol Med, 2024, 56(2):408-421.
Cell Discov, 2023, 9(1):7
Cell Death Dis, 2023, 14(7):467
S7033 GSK2656157 GSK2656157 is an ATP-competitive and highly selective inhibitor of PERK with IC50 of 0.9 nM in a cell-free assay, 500-fold greater against a panel of 300 kinases. GSK2656157 decreases apoptosis and inhibits excessive autophagy.
Nat Commun, 2023, 14(1):2132
Redox Biol, 2023, 65:102833
Cell Rep, 2023, 42(2):112023
S2923 Salubrinal Salubrinal is a selective inhibitor of eIF2α dephosphorylation and inhibits ER stress-mediated apoptosis with EC50 of ~15 μM in a cell-free assay.
Cell Death Dis, 2024, 15(1):31
Cell Rep, 2023, 42(2):112042
Int J Mol Sci, 2023, 24(23)16814
S7400 ISRIB (trans-isomer) ISRIB (trans-isomer), the trans-isomer of ISRIB, is a potent and selective PERK inhibitor with IC50 of 5 nM and does not have global effects on translation, transcription, or mRNA stability in non-stressed cells.
J Biol Chem, 2022, S0021-9258(22)01264-9
Clin Cancer Res, 2020, 10.1158/1078-0432.CCR-19-1900
Cell Death Dis, 2020, 6;11(1):17
S7437 Sal003 Sal003 is a potent and cell-permeable eIF-2α phosphatase inhibitor.
Front Pharmacol, 2023, 14:1095307
bioRxiv, 2023, 2023.05.19.540602
bioRxiv, 2023, 2023.05.19.540602
S8304 Azoramide Azoramide is a small-molecule modulator of the unfolded protein response (UPR). It improves ER protein-folding ability and activates ER chaperone capacity to protect cells against ER stress.
J Adv Res, 2022, S2090-1232(22)00149-7
Stem Cell Res, 2022, 60:102686
S0006 BTdCPU BTdCPU is a potent activator of heme regulated inhibitor kinase (HRI), one of eukaryotic translation initiation factor 2α kinases (eIF2α-kinases).
Front Cell Dev Biol, 2021, 9:675486
E1030 CCT020312 CCT020312 is a selective PERK (EIF2AK3) activator with an EC50 of 5.1 μM. CCT020312 can be used for the selective activation of EIF2A-mediated translation control.
Int J Mol Med, 2023, 52(1)56
S6952New MK-28 MK-28 is a potent and selective activator of PERK. MK-28 exhibits an IC50 ~3-fold higher than CCT020312 in rescuing mutant huntingtin protein (mHtt)-expressing striatal neurons from apoptosis. MK-28 exhibits remarkable pharmacokinetic properties and high BBB penetration in mice.
S7307 GSK2606414 GSK2606414 is an orally available, potent, and selective PERK inhibitor with IC50 of 0.4 nM, displaying at least 100-fold selectivity over the other EIF2AKs assayed. GSK2606414 impairs GANT-61 induced autophagy in NB cells with MYCN amplification. GSK2606414 exacerbates ER stress-induced apoptosis in HCT116 cells while reduces the apoptosis in SIL1 KD HeLa cells.
Exp Mol Med, 2024, 56(2):408-421.
Cell Discov, 2023, 9(1):7
Cell Death Dis, 2023, 14(7):467
S7033 GSK2656157 GSK2656157 is an ATP-competitive and highly selective inhibitor of PERK with IC50 of 0.9 nM in a cell-free assay, 500-fold greater against a panel of 300 kinases. GSK2656157 decreases apoptosis and inhibits excessive autophagy.
Nat Commun, 2023, 14(1):2132
Redox Biol, 2023, 65:102833
Cell Rep, 2023, 42(2):112023
S7400 ISRIB (trans-isomer) ISRIB (trans-isomer), the trans-isomer of ISRIB, is a potent and selective PERK inhibitor with IC50 of 5 nM and does not have global effects on translation, transcription, or mRNA stability in non-stressed cells.
J Biol Chem, 2022, S0021-9258(22)01264-9
Clin Cancer Res, 2020, 10.1158/1078-0432.CCR-19-1900
Cell Death Dis, 2020, 6;11(1):17
S0006 BTdCPU BTdCPU is a potent activator of heme regulated inhibitor kinase (HRI), one of eukaryotic translation initiation factor 2α kinases (eIF2α-kinases).
Front Cell Dev Biol, 2021, 9:675486
E1030 CCT020312 CCT020312 is a selective PERK (EIF2AK3) activator with an EC50 of 5.1 μM. CCT020312 can be used for the selective activation of EIF2A-mediated translation control.
Int J Mol Med, 2023, 52(1)56
S6952New MK-28 MK-28 is a potent and selective activator of PERK. MK-28 exhibits an IC50 ~3-fold higher than CCT020312 in rescuing mutant huntingtin protein (mHtt)-expressing striatal neurons from apoptosis. MK-28 exhibits remarkable pharmacokinetic properties and high BBB penetration in mice.
S2923 Salubrinal Salubrinal is a selective inhibitor of eIF2α dephosphorylation and inhibits ER stress-mediated apoptosis with EC50 of ~15 μM in a cell-free assay.
Cell Death Dis, 2024, 15(1):31
Cell Rep, 2023, 42(2):112042
Int J Mol Sci, 2023, 24(23)16814
S7437 Sal003 Sal003 is a potent and cell-permeable eIF-2α phosphatase inhibitor.
Front Pharmacol, 2023, 14:1095307
bioRxiv, 2023, 2023.05.19.540602
bioRxiv, 2023, 2023.05.19.540602
S8304 Azoramide Azoramide is a small-molecule modulator of the unfolded protein response (UPR). It improves ER protein-folding ability and activates ER chaperone capacity to protect cells against ER stress.
J Adv Res, 2022, S2090-1232(22)00149-7
Stem Cell Res, 2022, 60:102686
S6952New MK-28 MK-28 is a potent and selective activator of PERK. MK-28 exhibits an IC50 ~3-fold higher than CCT020312 in rescuing mutant huntingtin protein (mHtt)-expressing striatal neurons from apoptosis. MK-28 exhibits remarkable pharmacokinetic properties and high BBB penetration in mice.

PERK阻害剤の選択性比較

Tags: PERK inhibitor|PERK agonist|PERK activator|PERK inducer|PERK antagonist|PERK signaling pathway|PERK assay kit